NEAL KLEIMAN to Ticlopidine
This is a "connection" page, showing publications NEAL KLEIMAN has written about Ticlopidine.
Connection Strength
4.800
-
Are we there yet? deciding when it is safe (and wise) to stop clopidogrel after stent implantation. J Interv Cardiol. 2014 Apr; 27(2):127-30.
Score: 0.462
-
Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. J Thromb Thrombolysis. 2012 Feb; 33(2):137-42.
Score: 0.399
-
The safety of clopidogrel. Expert Opin Drug Saf. 2011 Jan; 10(1):85-95.
Score: 0.367
-
Searching for the ceiling: new reflections on the disposition and metabolism of clopidogrel. JACC Cardiovasc Interv. 2008 Dec; 1(6):628-30.
Score: 0.320
-
Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician? J Am Coll Cardiol. 2008 Nov 04; 52(19):1564-6.
Score: 0.319
-
Will measuring vasodilator-stimulated phosphoprotein phosphorylation help us optimize the loading dose of clopidogrel? J Am Coll Cardiol. 2008 Apr 08; 51(14):1412-4.
Score: 0.306
-
Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease. Am Heart J. 2007 Oct; 154(4):694.e1-7.
Score: 0.295
-
Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. J Thromb Thrombolysis. 2007 Aug; 24(1):15-21.
Score: 0.282
-
Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res. 2007; 119(3):355-60.
Score: 0.265
-
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006 Jan 03; 47(1):27-33.
Score: 0.261
-
Resistance to antiplatelet therapy. Curr Cardiol Rep. 2005 Jul; 7(4):242-8.
Score: 0.253
-
Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide? Nat Clin Pract Cardiovasc Med. 2005 Jul; 2(7):344-5.
Score: 0.253
-
Is This a Good Time to Revisit the?Tropics?: Platelet Function Testing in Patients With Acute Coronary Syndromes. JACC Cardiovasc Interv. 2021 02 22; 14(4):428-430.
Score: 0.186
-
Never So Simple: Bedside Measurement of Platelet Reactivity and the Risk?of?Stroke After Coronary Stenting. JACC Cardiovasc Interv. 2018 07 09; 11(13):1287-1289.
Score: 0.155
-
Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance. J Am Coll Cardiol. 2016 07 19; 68(3):294-296.
Score: 0.136
-
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways. Thromb Haemost. 2013 Dec; 110(6):1223-31.
Score: 0.111
-
Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry). Am J Cardiol. 2011 Jun 15; 107(12):1751-6.
Score: 0.095
-
Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol. 2009 Jul 15; 104(2):227-33.
Score: 0.083
-
Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol. 2008 Aug 26; 52(9):743-9.
Score: 0.079
-
Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. Am Heart J. 2007 Jan; 153(1):41.e1-6.
Score: 0.070
-
Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. Catheter Cardiovasc Interv. 2005 Mar; 64(3):369-72.
Score: 0.062
-
Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med. 2009 Dec 10; 361(24):2318-29.
Score: 0.021
-
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation. 2008 Jun 03; 117(22):2865-74.
Score: 0.019